Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care, and providers at all levels. is Guideline
should not be considered exclusive of other methods of care reasonably directed at obtaining the
same results. e ultimate judgment concerning the propriety of any course of conduct must be
made by the clinician aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated
with the distributor of this clinical reference tool.
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies: info@GuidelineCentral.com
Copyright © 2012 All rights reserved
References
Adapted from Reports of the Quality Standards Subcommittee of the American Academy of
Neurology. Miyasaki JM, Martin W, Suchowersky O, Weiner WJ, Lang AE. Practice parameter:
Initiation of treatment for Parkinson disease (an evidence-based review). Neurology,
2002;58:11-17. Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ.
Practice parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-
based review). Neurology, 2006;66:968-975. Suchowersky O, Gronseth G, Perlmutter J, Reich
S, Zesiewicz T, Weiner WJ. Practice parameter: Neuroprotective strategies and alternative
therapies for Parkinson disease (an evidence-based review). Neurology 2006;66:976-982. Pahwa
R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, et al. Practice parameter:
Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence based
review). Neurology 2006;66:983-995. Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman
G, Anderson K, et al. Practice parameter: Evaluation and treatment of depression, psychosis,
and dementia in Parkinson disease (an evidence-based review). Neurology 2006;66:996-1002.
